Liu Jing, Ding Yue, Liu Zhongmin, Liang Xiaoting
Research Center for Translational Medicine, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, China.
Department of Cardiovascular Surgery, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China.
Front Cell Dev Biol. 2020 May 5;8:258. doi: 10.3389/fcell.2020.00258. eCollection 2020.
Mesenchymal stem cells (MSCs) are multipotent cells capable of self-renewal and differentiation. There is increasing evidence of the therapeutic value of MSCs in various clinical situations, however, these cells gradually lose their regenerative potential with age, with a concomitant increase in cellular dysfunction. Stem cell aging and replicative exhaustion are considered as hallmarks of aging and functional attrition in organisms. MSCs do not proliferate infinitely but undergo only a limited number of population doublings before becoming senescent. This greatly hinders their clinical application, given that cultures must be expanded to obtain a sufficient number of cells for cell-based therapy. Here, we review the current knowledge of the phenotypic and functional characteristics of senescent MSCs, molecular mechanisms underlying MSCs aging, and strategies to rejuvenate senescent MSCs, which can broaden their range of therapeutic applications.
间充质干细胞(MSCs)是具有自我更新和分化能力的多能细胞。越来越多的证据表明MSCs在各种临床情况下具有治疗价值,然而,随着年龄的增长,这些细胞的再生潜力逐渐丧失,同时细胞功能障碍也随之增加。干细胞衰老和复制性耗竭被认为是生物体衰老和功能衰退的标志。MSCs不会无限增殖,而是在衰老之前只经历有限次数的群体倍增。这极大地阻碍了它们的临床应用,因为必须扩大培养物以获得足够数量的细胞用于基于细胞的治疗。在这里,我们综述了衰老MSCs的表型和功能特征、MSCs衰老的分子机制以及使衰老MSCs恢复活力的策略的当前知识,这可以拓宽它们的治疗应用范围。